Remiges Ventures

Remiges Ventures is a cross-border venture capital firm investing in early-stage life sciences companies with a focus on transformative therapeutics. The firm operates offices in Seattle, Washington, and Tokyo, Japan, and is dedicated to fostering innovation in the pharmaceutical and biotechnology sectors. Remiges Ventures specializes in creating new companies based on intellectual properties from Japanese academia, leveraging Japan's rich source of biopharma seed technologies. The firm manages RDiscovery, an incubator that nurtures drug discovery startups from pre-seed to Series A stages, facilitating the transition of innovative assets into mature development phases. Additionally, Remiges Ventures takes lead positions in global Series A or later-stage investment rounds, actively participating in the value creation for its portfolio companies through strategic guidance and management support. The firm's investment strategy encompasses a wide range of therapeutic areas and modalities, aiming to advance the development of novel drugs and medical devices. Remiges Ventures collaborates with key opinion leaders, serial entrepreneurs, and major pharmaceutical companies to enhance the growth and success of its investee companies. By combining expertise from both the United States and Japan, Remiges Ventures bridges the gap between these regions, promoting cross-border innovation and accelerating the commercialization of life sciences advancements. The firm's commitment to early-stage investments and company creation underscores its dedication to driving progress in the global healthcare landscape.